Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
Market Analysis and Insights: Global Infectious Disease Point of Care Diagnostics Market
The global Infectious Disease Point of Care Diagnostics market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Infectious Disease Point of Care Diagnostics Scope and Segment
The global Infectious Disease Point of Care Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Point of Care Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
By the application, this report covers the following segments
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Competitive Landscape:
The Infectious Disease Point of Care Diagnostics key manufacturers in this market include:
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Market Analysis and Insights: Global Infectious Disease Point of Care Diagnostics Market
The global Infectious Disease Point of Care Diagnostics market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Infectious Disease Point of Care Diagnostics Scope and Segment
The global Infectious Disease Point of Care Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Point of Care Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
By the application, this report covers the following segments
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
Competitive Landscape:
The Infectious Disease Point of Care Diagnostics key manufacturers in this market include:
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
1 Market Overview of Infectious Disease Point of Care Diagnostics
1.1 Infectious Disease Point of Care Diagnostics Market Overview
1.1.1 Infectious Disease Point of Care Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Infectious Disease Point of Care Diagnostics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Infectious Disease Point of Care Diagnostics Market Size by Region (2015-2026)
1.4 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2015-2020)
1.5 Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.1 North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.2 Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.3 China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
2 Infectious Disease Point of Care Diagnostics Market Overview by Type
2.1 Global Infectious Disease Point of Care Diagnostics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
2.3 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)
2.4 Over-the-counter (OTC) Testing Kits
2.5 Prescription-based Testing Kits
3 Infectious Disease Point of Care Diagnostics Market Overview by Application
3.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2015-2020)
3.3 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)
3.4 Bacterial Infections
3.5 Fungal Infection
3.6 Virus Infection
3.7 Cardiovascular Infection
3.8 Gastrointestinal Infection
3.9 Sexually Transmitted Disease (STD) Infection
3.10 Central Nervous System Infection
3.11 Other
4 Global Infectious Disease Point of Care Diagnostics Competition Analysis by Players
4.1 Global Infectious Disease Point of Care Diagnostics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
4.3 Date of Key Manufacturers Enter into Infectious Disease Point of Care Diagnostics Market
4.4 Global Top Players Infectious Disease Point of Care Diagnostics Headquarters and Area Served
4.5 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Point of Care Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business and Company’s Total Revenue
5.1.3 Abbott Products, Services and Solutions
5.1.4 Abbott Revenue (US$ Million) (2015-2020)
5.1.5 Abbott Recent Development and Reaction to Covid-19
5.2 Siemens
5.2.1 Siemens Profile
5.2.2 Siemens Main Business and Company’s Total Revenue
5.2.3 Siemens Products, Services and Solutions
5.2.4 Siemens Revenue (US$ Million) (2015-2020)
5.2.5 Siemens Recent Development and Reaction to Covid-19
5.3 GE Healthcare
5.5.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business and Company’s Total Revenue
5.3.3 GE Healthcare Products, Services and Solutions
5.3.4 GE Healthcare Revenue (US$ Million) (2015-2020)
5.3.5 Accriva Recent Development and Reaction to Covid-19
5.4 Accriva
5.4.1 Accriva Profile
5.4.2 Accriva Main Business and Company’s Total Revenue
5.4.3 Accriva Products, Services and Solutions
5.4.4 Accriva Revenue (US$ Million) (2015-2020)
5.4.5 Accriva Recent Development and Reaction to Covid-19
5.5 Terumo
5.5.1 Terumo Profile
5.5.2 Terumo Main Business and Company’s Total Revenue
5.5.3 Terumo Products, Services and Solutions
5.5.4 Terumo Revenue (US$ Million) (2015-2020)
5.5.5 Terumo Recent Development and Reaction to Covid-19
5.6 BioMerieux
5.6.1 BioMerieux Profile
5.6.2 BioMerieux Main Business and Company’s Total Revenue
5.6.3 BioMerieux Products, Services and Solutions
5.6.4 BioMerieux Revenue (US$ Million) (2015-2020)
5.6.5 BioMerieux Recent Development and Reaction to Covid-19
5.7 Diasorin
5.7.1 Diasorin Profile
5.7.2 Diasorin Main Business and Company’s Total Revenue
5.7.3 Diasorin Products, Services and Solutions
5.7.4 Diasorin Revenue (US$ Million) (2015-2020)
5.7.5 Diasorin Recent Development and Reaction to Covid-19
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business and Company’s Total Revenue
5.8.3 Roche Products, Services and Solutions
5.8.4 Roche Revenue (US$ Million) (2015-2020)
5.8.5 Roche Recent Development and Reaction to Covid-19
5.9 Danaher Corporation
5.9.1 Danaher Corporation Profile
5.9.2 Danaher Corporation Main Business and Company’s Total Revenue
5.9.3 Danaher Corporation Products, Services and Solutions
5.9.4 Danaher Corporation Revenue (US$ Million) (2015-2020)
5.9.5 Danaher Corporation Recent Development and Reaction to Covid-19
5.10 BD
5.10.1 BD Profile
5.10.2 BD Main Business and Company’s Total Revenue
5.10.3 BD Products, Services and Solutions
5.10.4 BD Revenue (US$ Million) (2015-2020)
5.10.5 BD Recent Development and Reaction to Covid-19
5.11 Bio-Rad Laboratories
5.11.1 Bio-Rad Laboratories Profile
5.11.2 Bio-Rad Laboratories Main Business and Company’s Total Revenue
5.11.3 Bio-Rad Laboratories Products, Services and Solutions
5.11.4 Bio-Rad Laboratories Revenue (US$ Million) (2015-2020)
5.11.5 Bio-Rad Laboratories Recent Development and Reaction to Covid-19
5.12 Cavidi
5.12.1 Cavidi Profile
5.12.2 Cavidi Main Business and Company’s Total Revenue
5.12.3 Cavidi Products, Services and Solutions
5.12.4 Cavidi Revenue (US$ Million) (2015-2020)
5.12.5 Cavidi Recent Development and Reaction to Covid-19
5.13 Cepheid
5.13.1 Cepheid Profile
5.13.2 Cepheid Main Business and Company’s Total Revenue
5.13.3 Cepheid Products, Services and Solutions
5.13.4 Cepheid Revenue (US$ Million) (2015-2020)
5.13.5 Cepheid Recent Development and Reaction to Covid-19
5.14 Diaxonhit
5.14.1 Diaxonhit Profile
5.14.2 Diaxonhit Main Business and Company’s Total Revenue
5.14.3 Diaxonhit Products, Services and Solutions
5.14.4 Diaxonhit Revenue (US$ Million) (2015-2020)
5.14.5 Diaxonhit Recent Development and Reaction to Covid-19
5.15 Eiken Chemical
5.15.1 Eiken Chemical Profile
5.15.2 Eiken Chemical Main Business and Company’s Total Revenue
5.15.3 Eiken Chemical Products, Services and Solutions
5.15.4 Eiken Chemical Revenue (US$ Million) (2015-2020)
5.15.5 Eiken Chemical Recent Development and Reaction to Covid-19
5.16 EMD Millipore
5.16.1 EMD Millipore Profile
5.16.2 EMD Millipore Main Business and Company’s Total Revenue
5.16.3 EMD Millipore Products, Services and Solutions
5.16.4 EMD Millipore Revenue (US$ Million) (2015-2020)
5.16.5 EMD Millipore Recent Development and Reaction to Covid-19
5.17 Epitope Diagnostic
5.17.1 Epitope Diagnostic Profile
5.17.2 Epitope Diagnostic Main Business and Company’s Total Revenue
5.17.3 Epitope Diagnostic Products, Services and Solutions
5.17.4 Epitope Diagnostic Revenue (US$ Million) (2015-2020)
5.17.5 Epitope Diagnostic Recent Development and Reaction to Covid-19
5.18 Euroimmun
5.18.1 Euroimmun Profile
5.18.2 Euroimmun Main Business and Company’s Total Revenue
5.18.3 Euroimmun Products, Services and Solutions
5.18.4 Euroimmun Revenue (US$ Million) (2015-2020)
5.18.5 Euroimmun Recent Development and Reaction to Covid-19
5.19 Gold Standard Diagnostics
5.19.1 Gold Standard Diagnostics Profile
5.19.2 Gold Standard Diagnostics Main Business and Company’s Total Revenue
5.19.3 Gold Standard Diagnostics Products, Services and Solutions
5.19.4 Gold Standard Diagnostics Revenue (US$ Million) (2015-2020)
5.19.5 Gold Standard Diagnostics Recent Development and Reaction to Covid-19
5.20 Hologic
5.20.1 Hologic Profile
5.20.2 Hologic Main Business and Company’s Total Revenue
5.20.3 Hologic Products, Services and Solutions
5.20.4 Hologic Revenue (US$ Million) (2015-2020)
5.20.5 Hologic Recent Development and Reaction to Covid-19
5.21 Immunetics
5.21.1 Immunetics Profile
5.21.2 Immunetics Main Business and Company’s Total Revenue
5.21.3 Immunetics Products, Services and Solutions
5.21.4 Immunetics Revenue (US$ Million) (2015-2020)
5.21.5 Immunetics Recent Development and Reaction to Covid-19
5.22 InBios International
5.22.1 InBios International Profile
5.22.2 InBios International Main Business and Company’s Total Revenue
5.22.3 InBios International Products, Services and Solutions
5.22.4 InBios International Revenue (US$ Million) (2015-2020)
5.22.5 InBios International Recent Development and Reaction to Covid-19
6 North America Infectious Disease Point of Care Diagnostics by Players and by Application
6.1 North America Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
7 Europe Infectious Disease Point of Care Diagnostics by Players and by Application
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
8 China Infectious Disease Point of Care Diagnostics by Players and by Application
8.1 China Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
8.2 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics by Players and by Application
9.1 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
10 Latin America Infectious Disease Point of Care Diagnostics by Players and by Application
10.1 Latin America Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
11 Middle East & Africa Infectious Disease Point of Care Diagnostics by Players and by Application
11.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
12 Infectious Disease Point of Care Diagnostics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Infectious Disease Point of Care Diagnostics Market Overview
1.1.1 Infectious Disease Point of Care Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Infectious Disease Point of Care Diagnostics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Infectious Disease Point of Care Diagnostics Market Size by Region (2015-2026)
1.4 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2015-2020)
1.5 Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.1 North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.2 Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.3 China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2026)
2 Infectious Disease Point of Care Diagnostics Market Overview by Type
2.1 Global Infectious Disease Point of Care Diagnostics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
2.3 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)
2.4 Over-the-counter (OTC) Testing Kits
2.5 Prescription-based Testing Kits
3 Infectious Disease Point of Care Diagnostics Market Overview by Application
3.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2015-2020)
3.3 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)
3.4 Bacterial Infections
3.5 Fungal Infection
3.6 Virus Infection
3.7 Cardiovascular Infection
3.8 Gastrointestinal Infection
3.9 Sexually Transmitted Disease (STD) Infection
3.10 Central Nervous System Infection
3.11 Other
4 Global Infectious Disease Point of Care Diagnostics Competition Analysis by Players
4.1 Global Infectious Disease Point of Care Diagnostics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
4.3 Date of Key Manufacturers Enter into Infectious Disease Point of Care Diagnostics Market
4.4 Global Top Players Infectious Disease Point of Care Diagnostics Headquarters and Area Served
4.5 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Point of Care Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business and Company’s Total Revenue
5.1.3 Abbott Products, Services and Solutions
5.1.4 Abbott Revenue (US$ Million) (2015-2020)
5.1.5 Abbott Recent Development and Reaction to Covid-19
5.2 Siemens
5.2.1 Siemens Profile
5.2.2 Siemens Main Business and Company’s Total Revenue
5.2.3 Siemens Products, Services and Solutions
5.2.4 Siemens Revenue (US$ Million) (2015-2020)
5.2.5 Siemens Recent Development and Reaction to Covid-19
5.3 GE Healthcare
5.5.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business and Company’s Total Revenue
5.3.3 GE Healthcare Products, Services and Solutions
5.3.4 GE Healthcare Revenue (US$ Million) (2015-2020)
5.3.5 Accriva Recent Development and Reaction to Covid-19
5.4 Accriva
5.4.1 Accriva Profile
5.4.2 Accriva Main Business and Company’s Total Revenue
5.4.3 Accriva Products, Services and Solutions
5.4.4 Accriva Revenue (US$ Million) (2015-2020)
5.4.5 Accriva Recent Development and Reaction to Covid-19
5.5 Terumo
5.5.1 Terumo Profile
5.5.2 Terumo Main Business and Company’s Total Revenue
5.5.3 Terumo Products, Services and Solutions
5.5.4 Terumo Revenue (US$ Million) (2015-2020)
5.5.5 Terumo Recent Development and Reaction to Covid-19
5.6 BioMerieux
5.6.1 BioMerieux Profile
5.6.2 BioMerieux Main Business and Company’s Total Revenue
5.6.3 BioMerieux Products, Services and Solutions
5.6.4 BioMerieux Revenue (US$ Million) (2015-2020)
5.6.5 BioMerieux Recent Development and Reaction to Covid-19
5.7 Diasorin
5.7.1 Diasorin Profile
5.7.2 Diasorin Main Business and Company’s Total Revenue
5.7.3 Diasorin Products, Services and Solutions
5.7.4 Diasorin Revenue (US$ Million) (2015-2020)
5.7.5 Diasorin Recent Development and Reaction to Covid-19
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business and Company’s Total Revenue
5.8.3 Roche Products, Services and Solutions
5.8.4 Roche Revenue (US$ Million) (2015-2020)
5.8.5 Roche Recent Development and Reaction to Covid-19
5.9 Danaher Corporation
5.9.1 Danaher Corporation Profile
5.9.2 Danaher Corporation Main Business and Company’s Total Revenue
5.9.3 Danaher Corporation Products, Services and Solutions
5.9.4 Danaher Corporation Revenue (US$ Million) (2015-2020)
5.9.5 Danaher Corporation Recent Development and Reaction to Covid-19
5.10 BD
5.10.1 BD Profile
5.10.2 BD Main Business and Company’s Total Revenue
5.10.3 BD Products, Services and Solutions
5.10.4 BD Revenue (US$ Million) (2015-2020)
5.10.5 BD Recent Development and Reaction to Covid-19
5.11 Bio-Rad Laboratories
5.11.1 Bio-Rad Laboratories Profile
5.11.2 Bio-Rad Laboratories Main Business and Company’s Total Revenue
5.11.3 Bio-Rad Laboratories Products, Services and Solutions
5.11.4 Bio-Rad Laboratories Revenue (US$ Million) (2015-2020)
5.11.5 Bio-Rad Laboratories Recent Development and Reaction to Covid-19
5.12 Cavidi
5.12.1 Cavidi Profile
5.12.2 Cavidi Main Business and Company’s Total Revenue
5.12.3 Cavidi Products, Services and Solutions
5.12.4 Cavidi Revenue (US$ Million) (2015-2020)
5.12.5 Cavidi Recent Development and Reaction to Covid-19
5.13 Cepheid
5.13.1 Cepheid Profile
5.13.2 Cepheid Main Business and Company’s Total Revenue
5.13.3 Cepheid Products, Services and Solutions
5.13.4 Cepheid Revenue (US$ Million) (2015-2020)
5.13.5 Cepheid Recent Development and Reaction to Covid-19
5.14 Diaxonhit
5.14.1 Diaxonhit Profile
5.14.2 Diaxonhit Main Business and Company’s Total Revenue
5.14.3 Diaxonhit Products, Services and Solutions
5.14.4 Diaxonhit Revenue (US$ Million) (2015-2020)
5.14.5 Diaxonhit Recent Development and Reaction to Covid-19
5.15 Eiken Chemical
5.15.1 Eiken Chemical Profile
5.15.2 Eiken Chemical Main Business and Company’s Total Revenue
5.15.3 Eiken Chemical Products, Services and Solutions
5.15.4 Eiken Chemical Revenue (US$ Million) (2015-2020)
5.15.5 Eiken Chemical Recent Development and Reaction to Covid-19
5.16 EMD Millipore
5.16.1 EMD Millipore Profile
5.16.2 EMD Millipore Main Business and Company’s Total Revenue
5.16.3 EMD Millipore Products, Services and Solutions
5.16.4 EMD Millipore Revenue (US$ Million) (2015-2020)
5.16.5 EMD Millipore Recent Development and Reaction to Covid-19
5.17 Epitope Diagnostic
5.17.1 Epitope Diagnostic Profile
5.17.2 Epitope Diagnostic Main Business and Company’s Total Revenue
5.17.3 Epitope Diagnostic Products, Services and Solutions
5.17.4 Epitope Diagnostic Revenue (US$ Million) (2015-2020)
5.17.5 Epitope Diagnostic Recent Development and Reaction to Covid-19
5.18 Euroimmun
5.18.1 Euroimmun Profile
5.18.2 Euroimmun Main Business and Company’s Total Revenue
5.18.3 Euroimmun Products, Services and Solutions
5.18.4 Euroimmun Revenue (US$ Million) (2015-2020)
5.18.5 Euroimmun Recent Development and Reaction to Covid-19
5.19 Gold Standard Diagnostics
5.19.1 Gold Standard Diagnostics Profile
5.19.2 Gold Standard Diagnostics Main Business and Company’s Total Revenue
5.19.3 Gold Standard Diagnostics Products, Services and Solutions
5.19.4 Gold Standard Diagnostics Revenue (US$ Million) (2015-2020)
5.19.5 Gold Standard Diagnostics Recent Development and Reaction to Covid-19
5.20 Hologic
5.20.1 Hologic Profile
5.20.2 Hologic Main Business and Company’s Total Revenue
5.20.3 Hologic Products, Services and Solutions
5.20.4 Hologic Revenue (US$ Million) (2015-2020)
5.20.5 Hologic Recent Development and Reaction to Covid-19
5.21 Immunetics
5.21.1 Immunetics Profile
5.21.2 Immunetics Main Business and Company’s Total Revenue
5.21.3 Immunetics Products, Services and Solutions
5.21.4 Immunetics Revenue (US$ Million) (2015-2020)
5.21.5 Immunetics Recent Development and Reaction to Covid-19
5.22 InBios International
5.22.1 InBios International Profile
5.22.2 InBios International Main Business and Company’s Total Revenue
5.22.3 InBios International Products, Services and Solutions
5.22.4 InBios International Revenue (US$ Million) (2015-2020)
5.22.5 InBios International Recent Development and Reaction to Covid-19
6 North America Infectious Disease Point of Care Diagnostics by Players and by Application
6.1 North America Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
7 Europe Infectious Disease Point of Care Diagnostics by Players and by Application
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
8 China Infectious Disease Point of Care Diagnostics by Players and by Application
8.1 China Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
8.2 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics by Players and by Application
9.1 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
10 Latin America Infectious Disease Point of Care Diagnostics by Players and by Application
10.1 Latin America Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
11 Middle East & Africa Infectious Disease Point of Care Diagnostics by Players and by Application
11.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
12 Infectious Disease Point of Care Diagnostics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
